Minerva Neurosciences - 5 Year Stock Price History | NERV

Historical daily share price chart and data for Minerva Neurosciences since 2014 adjusted for splits. The latest closing stock price for Minerva Neurosciences as of July 16, 2019 is 6.39.
  • The all-time high Minerva Neurosciences stock price is 14.38, which is 125% above the current share price.
  • The Minerva Neurosciences 52-week high stock price is 12.55, which is 96.4% above the current share price.
  • The Minerva Neurosciences 52-week low stock price is 4.20, which is 34.3% below the current share price.
  • The average Minerva Neurosciences stock price for the last 52 weeks is 8.00.
Minerva Neurosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 6.8449 6.9200 8.4600 4.2000 6.3900 -5.19%
2018 8.0495 6.2000 12.5500 5.0500 6.7400 11.40%
2017 7.7839 11.7500 12.3500 4.9500 6.0500 -48.51%
2016 9.5805 5.8800 14.3800 3.5400 11.7500 93.57%
2015 5.3692 6.1100 6.4900 4.3400 6.0700 0.83%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.252B $0.000B
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.361B 34.73
Astellas Pharma (ALPMY) Japan $28.294B 13.87
Takeda Pharmaceutical (TAK) Japan $28.107B 8.25
Eisai (ESALY) Japan $16.062B 27.62
UCB SA (UCBJF) Belgium $15.866B 0.00
Grifols, S.A (GRFS) Spain $14.831B 18.76
Merck (MKGAF) Germany $13.435B 18.33
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Sage Therapeutics (SAGE) United States $9.586B 0.00
Ionis Pharmaceuticals (IONS) United States $9.522B 20.82
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $7.992B 0.00
Catalent (CTLT) United States $7.866B 31.57
Jazz Pharmaceuticals (JAZZ) Ireland $7.641B 10.48
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Nektar Therapeutics (NKTR) United States $5.789B 9.43
STADA ARZNEIMI (STDAF) Germany $5.634B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.420B 0.00
Orion OYJ (ORINY) Finland $5.275B 24.34
Hypermarcas (HYPMY) Brazil $4.894B 17.20
Evotec AG (EVTCY) Germany $4.308B 46.24
Tilray (TLRY) Canada $4.300B 0.00
FibroGen (FGEN) United States $4.000B 0.00
United Therapeutics (UTHR) United States $3.338B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.172B 11.39
Arrowhead Pharmaceuticals (ARWR) United States $2.636B 397.14
PTC Therapeutics (PTCT) United States $2.549B 0.00
Xencor (XNCR) United States $2.481B 67.72
Zogenix (ZGNX) United States $2.005B 0.00
Portola Pharmaceuticals (PTLA) United States $1.776B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.687B 81.72
Enanta Pharmaceuticals (ENTA) United States $1.609B 21.99
Ironwood Pharmaceuticals (IRWD) United States $1.607B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Heron Therapeutics (HRTX) United States $1.448B 0.00
USANA Health Sciences (USNA) United States $1.388B 12.06
Corcept Therapeutics (CORT) United States $1.223B 17.46
ArQule (ARQL) United States $1.162B 0.00
Aerie Pharmaceuticals (AERI) United States $1.159B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.048B 3.77
Radius Health (RDUS) United States $1.014B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.983B 0.00
Endo (ENDP) Ireland $0.893B 1.44
Spectrum Pharmaceuticals (SPPI) United States $0.887B 0.00
Concordia (CXRXF) Canada $0.719B 0.00
Aptorum Group (APM) China $0.673B 0.00
Organogenesis Holdings (ORGO) United States $0.623B 0.00
TherapeuticsMD (TXMD) United States $0.598B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.583B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.580B 0.00
GlycoMimetics (GLYC) United States $0.555B 0.00
Karyopharm Therapeutics (KPTI) United States $0.511B 0.00
Akebia Therapeutics (AKBA) United States $0.503B 0.00
Translate Bio (TBIO) United States $0.499B 0.00
ChemoCentryx (CCXI) United States $0.479B 0.00
Siga Technologies (SIGA) United States $0.469B 1.11
Dermira (DERM) United States $0.462B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.460B 23.19
Dova Pharmaceuticals (DOVA) United States $0.453B 0.00
Flexion Therapeutics (FLXN) United States $0.435B 0.00
CannTrust Holdings (CTST) Canada $0.432B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.422B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.420B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.420B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.407B 0.00
CV Sciences (CVSI) United States $0.405B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Indivior (INVVY) United States $0.393B 1.42
Collegium Pharmaceutical (COLL) United States $0.375B 0.00
ImmunoGen (IMGN) United States $0.371B 0.00
Innate Pharma SA (IPHYF) France $0.369B 0.00
Harpoon Therapeutics (HARP) United States $0.366B 0.00
Xeris Pharmaceuticals (XERS) United States $0.322B 0.00
OptiNose (OPTN) United States $0.304B 0.00
Rafael Holdings (RFL) United States $0.299B 0.00
KalVista Pharmaceuticals (KALV) United States $0.293B 0.00
Concert Pharmaceuticals (CNCE) United States $0.272B 0.00
Molecular Templates (MTEM) United States $0.264B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.250B 0.00
Aratana Therapeutics (PETX) United States $0.248B 0.00
Lannett Co Inc (LCI) United States $0.229B 2.23
Ocular Therapeutix (OCUL) United States $0.227B 0.00
Recro Pharma (REPH) United States $0.225B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.224B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.211B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.174B 0.00
Calithera Biosciences (CALA) United States $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.173B 0.00
IMV INC (IMV) Canada $0.170B 0.00
Nature's Sunshine Products (NATR) United States $0.167B 54.00
Taiwan Liposome (TLC) Taiwan $0.164B 0.00
Ardelyx (ARDX) United States $0.159B 0.00
MEI Pharma (MEIP) United States $0.150B 0.00
Jounce Therapeutics (JNCE) United States $0.141B 0.00
Majesco Entertainment (PTE) United States $0.141B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.139B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.124B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.122B 0.00
AgeX Therapeutics (AGE) United States $0.113B 0.00
DURECT (DRRX) United States $0.111B 0.00
Champions Oncology (CSBR) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.104B 0.00
Generex Biotechnology (GNBT) United States $0.099B 0.00
Infinity Pharmaceuticals (INFI) United States $0.096B 0.00
Capnia (SLNO) United States $0.095B 0.00
RENEURON GP (RNUGF) United Kingdom $0.094B 0.00
Mast Therapeutics (SVRA) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Genocea Biosciences (GNCA) United States $0.093B 0.00
Aclaris Therapeutics (ACRS) United States $0.092B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.089B 63.89
MediWound (MDWD) Israel $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.083B 8.27
Avadel Pharmaceuticals (AVDL) Ireland $0.082B 0.00
Cardiome Pharma (CORV) Canada $0.080B 0.00
Nivalis Therapeutics (ALPN) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
China SXT Pharmaceuticals (SXTC) China $0.077B 0.00
Novan (NOVN) United States $0.075B 0.00
Pharmaxis (PXSLY) Australia $0.071B 0.00
Neos Therapeutics (NEOS) United States $0.071B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.069B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
India Globalization Capital (IGC) United States $0.060B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.059B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00